Clinical trial
Longterm Follow-up of Subjects Treated With bb2121
NCT02786511 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longterm Follow-up of Subjects Treated With bb2121
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 28, 2016
- Completion date
- October 11, 2019
- Enrollment
- 50 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.